Bozic Carmen 4
4 · VERTEX PHARMACEUTICALS INC / MA · Filed Mar 3, 2026
Research Summary
AI-generated summary of this filing
Vertex (VRTX) CMO Carmen Bozic Sells 2,329 Shares
What Happened
- Carmen Bozic, EVP and Chief Medical Officer of Vertex Pharmaceuticals (VRTX), sold 2,329 shares on 2026-02-27 at $480.31 per share, generating proceeds of approximately $1,118,642. The Form 4 lists the transaction as a sale (S), described as an open-market or private sale.
Key Details
- Transaction date and price: 2026-02-27 at $480.31 per share
- Shares sold / proceeds: 2,329 shares for ~$1,118,642
- Filing date / timeliness: Form 4 filed 2026-03-03 for a report period of 2026-02-27 — filing appears timely
- Shares owned after transaction: Not specified in the provided filing
- Footnote: Transaction executed pursuant to a company-approved Rule 10b5-1 trading plan entered 11/20/2025 (preplanned sale)
Context
- Sales under a 10b5-1 plan are prearranged and routine; they do not necessarily signal a change in the insider’s view of the company. For retail investors, purchases typically carry more interpretive weight than routine sales.
Insider Transaction Report
Form 4
Bozic Carmen
EVP and CMO
Transactions
- Sale
Common Stock
[F1]2026-02-27$480.31/sh−2,329$1,118,642→ 37,734 total
Footnotes (1)
- [F1]Transaction made pursuant to Dr. Bozic's company approved trading plan under Rule 10b5-1, which was entered into on 11/20/2025.
Signature
/s/ Christiana Stevenson, Attorney-in-Fact|2026-03-03